XOMA Royalty Corporation (FRA:X0M1)

Market Cap	267.45M -16.9%
Revenue (ttm)	40.15M +118.0%
Net Income	8.40M
EPS	0.70
Shares Out	n/a
PE Ratio	31.84
Forward PE	21.07
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	15
Open	20.20
Previous Close	20.00
Day's Range	20.00 - 20.40
52-Week Range	16.30 - 33.20
Beta	n/a
RSI	40.83
Earnings Date	Mar 9, 2026

About XOMA Royalty

XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1981
• Employees: 13
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: X0M1

Financial Performance

In 2024, XOMA Royalty's revenue was $28.49 million, an increase of 498.72% compared to the previous year's $4.76 million. Losses were -$19.29 million, -58.33% less than in 2023.

Financial numbers in USD